Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03647969
Title Modified FOLFOX Plus/Minus Nivolumab and Ipilimumab vs. FLOT Plus Nivolumab in Patients With Previously Untreated Advanced or Metastatic Gastric Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Institut fur Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Indications

stomach cancer

gastroesophageal junction adenocarcinoma

Therapies

Docetaxel + Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin

Fluorouracil + Leucovorin + Oxaliplatin

Fluorouracil + Ipilimumab + Leucovorin + Nivolumab + Oxaliplatin

Age Groups: adult | senior
Covered Countries DEU


No variant requirements are available.